NM_198576.4:c.1384+28G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_198576.4(AGRN):​c.1384+28G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.897 in 1,576,312 control chromosomes in the GnomAD database, including 643,747 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.79 ( 50654 hom., cov: 34)
Exomes 𝑓: 0.91 ( 593093 hom. )

Consequence

AGRN
NM_198576.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.73

Publications

5 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 1-1042190-G-A is Benign according to our data. Variant chr1-1042190-G-A is described in ClinVar as Benign. ClinVar VariationId is 263159.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.946 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.1384+28G>A intron_variant Intron 7 of 35 ENST00000379370.7 NP_940978.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.1384+28G>A intron_variant Intron 7 of 35 1 NM_198576.4 ENSP00000368678.2
AGRNENST00000651234.1 linkc.1069+28G>A intron_variant Intron 6 of 37 ENSP00000499046.1
AGRNENST00000652369.2 linkc.1069+28G>A intron_variant Intron 6 of 34 ENSP00000498543.1
AGRNENST00000620552.4 linkc.970+28G>A intron_variant Intron 7 of 38 5 ENSP00000484607.1

Frequencies

GnomAD3 genomes
AF:
0.788
AC:
119832
AN:
152074
Hom.:
50662
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.441
Gnomad AMI
AF:
0.986
Gnomad AMR
AF:
0.883
Gnomad ASJ
AF:
0.920
Gnomad EAS
AF:
0.968
Gnomad SAS
AF:
0.947
Gnomad FIN
AF:
0.940
Gnomad MID
AF:
0.879
Gnomad NFE
AF:
0.918
Gnomad OTH
AF:
0.825
GnomAD2 exomes
AF:
0.897
AC:
193293
AN:
215414
AF XY:
0.905
show subpopulations
Gnomad AFR exome
AF:
0.435
Gnomad AMR exome
AF:
0.932
Gnomad ASJ exome
AF:
0.918
Gnomad EAS exome
AF:
0.973
Gnomad FIN exome
AF:
0.937
Gnomad NFE exome
AF:
0.915
Gnomad OTH exome
AF:
0.899
GnomAD4 exome
AF:
0.909
AC:
1294784
AN:
1424120
Hom.:
593093
Cov.:
45
AF XY:
0.911
AC XY:
642591
AN XY:
704992
show subpopulations
African (AFR)
AF:
0.418
AC:
13784
AN:
33006
American (AMR)
AF:
0.925
AC:
40133
AN:
43406
Ashkenazi Jewish (ASJ)
AF:
0.915
AC:
23040
AN:
25186
East Asian (EAS)
AF:
0.970
AC:
37881
AN:
39062
South Asian (SAS)
AF:
0.943
AC:
79304
AN:
84054
European-Finnish (FIN)
AF:
0.932
AC:
35517
AN:
38090
Middle Eastern (MID)
AF:
0.851
AC:
4782
AN:
5616
European-Non Finnish (NFE)
AF:
0.919
AC:
1007802
AN:
1096634
Other (OTH)
AF:
0.890
AC:
52541
AN:
59066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
6149
12297
18446
24594
30743
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21410
42820
64230
85640
107050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.787
AC:
119841
AN:
152192
Hom.:
50654
Cov.:
34
AF XY:
0.793
AC XY:
59006
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.441
AC:
18266
AN:
41466
American (AMR)
AF:
0.883
AC:
13521
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.920
AC:
3192
AN:
3470
East Asian (EAS)
AF:
0.968
AC:
5011
AN:
5176
South Asian (SAS)
AF:
0.946
AC:
4568
AN:
4830
European-Finnish (FIN)
AF:
0.940
AC:
9981
AN:
10620
Middle Eastern (MID)
AF:
0.873
AC:
255
AN:
292
European-Non Finnish (NFE)
AF:
0.918
AC:
62401
AN:
68008
Other (OTH)
AF:
0.826
AC:
1747
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
967
1935
2902
3870
4837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
836
1672
2508
3344
4180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.863
Hom.:
10711
Bravo
AF:
0.766
Asia WGS
AF:
0.921
AC:
3205
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital myasthenic syndrome 8 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.15
DANN
Benign
0.66
PhyloP100
-1.7
RBP_binding_hub_radar
0.85
RBP_regulation_power_radar
2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2710876; hg19: chr1-977570; API